Gamma Investing LLC Tarsus Pharmaceuticals, Inc. Transaction History
Gamma Investing LLC
- $18.8 Billion
- Q1 2025
A detailed history of Gamma Investing LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 13,151 shares of TARS stock, worth $647,686. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,151
Previous 36
36430.56%
Holding current value
$647,686
Previous $1.99 Million
87.16%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TARS
# of Institutions
202Shares Held
40.4MCall Options Held
72.7KPut Options Held
313K-
Black Rock Inc. New York, NY3.27MShares$161 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$159 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$125 Million5.35% of portfolio
-
Jennison Associates LLC2.5MShares$123 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$111 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.31B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...